BSE filing, NSE: SENORES. Summary written from the filing by ALFA Finder's alert engine.
Senores Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,155.20
- Market cap
- ₹5,320 Cr
- Revenue (annual)
- ₹632.6 Cr
- Net profit (annual)
- ₹115.4 Cr
- P/E (TTM)
- 39.9×Sector 42.0×
- Promoter holding
- 45.82%+0.00% QoQ
- FII holding
- 6.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Senores Pharmaceuticals Ltd
All →Senores Pharmaceuticals Earnings Call Transcript: Key Takeaways
Senores delivered record quarterly revenue and EBITDA, driven by US portfolio expansion and regulated market growth.
- Call
- Guides 40% growth
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
Senores Pharmaceuticals Capacity Expansion: ₹20 Cr Investment
Senores Pharmaceuticals' subsidiary Apnar Pharma Private Limited plans a 0.7 Bn unit capacity addition by March 2027. The investment is Rs.20.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹20.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.7 Bn units
Senores Pharmaceuticals Capacity Expansion: ₹18 Cr Investment
Senores Pharmaceuticals plans to add 0.8 Bn units of capacity to its existing 1.2 Bn unit plant by March 2027. The investment is Rs.18.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹18.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.8 Bn units
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Senores Pharmaceuticals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹192.3 Cr (+24.9%), EBITDA ₹57.7 Cr (+38.3%, 30.0% margin), PAT ₹36.6 Cr. H1 revenue +30%, EBITDA +58.2%.
Other promoter selling (off-market) announcements
All →Cubical Financial Services Promoter Selling (Off-Market)
Promoter Ashwani Kumar Gupta sold 1,63,83,572 shares, or 11.28%, under a share purchase agreement. He has ceased to be a promoter.
Gallantt Ispat Promoter Selling (Off-Market)
Promoter and director Dinesh R. Agarwal disposed of 50 lakh Gallantt Ispat shares by gift on November 3, 2026. His holding fell from 5.65% to 3.57%.
Gowra Leasing & Finance Promoter Selling (Off-Market)
Gowra Leasing promoter group members transferred 15,740 shares off-market, with no consideration paid. The transfer moved shares between promoter group members, so promoter holdings were redistributed.
Baba Arts Promoter Selling (Off-Market): ₹3.9 Cr
Promoter Gordhan Tanwani completed the off-market transfer of 65 lakh Baba Arts shares to Skybridge Interactive LLP. The final tranche is valued at Rs 3.90 Crore.
- Value
- ₹3.90 Cr
Shri Dinesh Mills Promoter Selling (Off-Market)
Promoter Arushaben Patel gifted all 7,68,852 Shri Dinesh Mills shares to promoter Nimish Patel in an inter-se transfer. No cash consideration was involved.
Castrol India Promoter Selling (Off-Market)
BP p.l.c. indirectly sold its 51% Castrol India stake via Castrol Group Holdings on October 30, 2026. Its holding falls to nil, with no stated consideration.